𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Red cell antibodies in frequently transfused patients with myelodysplastic syndrome

✍ Scribed by G. Stiegler; W. Sperr; C. Lorber; V. Fabrizii; P. Höcker; S. Panzer

Book ID
105990583
Publisher
Springer
Year
2001
Tongue
English
Weight
28 KB
Volume
80
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Red blood cell transfusions and iron ove
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes
✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie

Transfusion intensity, not the cumulativ
Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support
✍ Arturo Pereira; Meritxell Nomdedeu; Josep-Lluís Aguilar; Mohamed Belkaid; Anna C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Transfusion‐dependency is associated with poor prognosis in patients with MDS although the causal link for such association is disputed. This study tests thee hypotheses on the association between transfusion burden and prognosis in the MDS: (1) the cumulative transfusion burden is a co